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Abstract
This study investigated the specific patient factors that predict responsiveness to a cognitive rehabilitation program.
The program has previously been demonstrated to be successful at the group level in patients with gliomas, but it is
unclear which patient characteristics optimized the effect of the intervention at the individual level. Four categories of
possible predictors of improvement were selected for evaluation: sociodemographic and clinical variables, self-reported
cognitive symptoms, and objective neuropsychological test performance. Hierarchical logistic regression analyses were
conducted, beginning with the most accessible (sociodemographic) variables and ending with the most difficult (baseline
neuropsychological) to identify in clinical practice. Nearly 60% of the participants of the intervention were classified as
reliably improved. Reliable improvement was predicted by age (p 5 .003) and education (p 5 .011). Additional results
suggested that younger patients were more likely to benefit specifically from the cognitive rehabilitation program
(p 5 .001), and that higher education was also associated with improvement in the control group (p 5 .024). The findings
are discussed in light of brain reserve theory. A practical implication is that cognitive rehabilitation programs should take
the patients’ age into account and, if possible, adapt programs to increase the likelihood of improvement among older
participants. (JINS, 2011, 17, 256–266)
Keywords: Neuropsychological rehabilitation, Brain tumor, Prediction, Individual change, Reliable change, Cognitive
impairment
INTRODUCTION
Patients with a glioma, the most common primary brain
tumor, may experience deficits in several cognitive domains,
including attention, memory, and executive functioning
(Klein et al., 2001; Laack et al., 2005; Meyers & Brown,
2006). The peak age of onset for low-grade (less malignant
but not benign) gliomas lies between 30 and 40 years
(DeAngelis, 2001). Both the tumor itself and its treatment can
cause these deficits. Deficits in patients with a low-grade
glioma are usually not severe (Anderson, Damasio, & Tranel,
1990; Correa et al., 2008; Laack et al., 2005), but they can
have a substantial impact on daily life (Meyers, Berger, &
Prados, 2005). Particularly during the disease-free period,
which can last for years, when patients are attempting to
resume their normal work and social activities, these deficits
can play a significant role. Moreover, subjective cognitive
symptoms are among the most common problems reported
by patients with brain tumors (Lidstone et al., 2003; Mukand,
Blackinton, Crincoli, Lee, & Santos, 2001).
In a recent study (Gehring et al., 2009), we reported the
results of a randomized controlled trial of cognitive rehabili-
tation in 140 patients with a glioma, in which positive group
effects were observed. In particular, the intervention group
performed significantly better than the control group on neuro-
psychological tests of attention and verbal memory 6 months
after undergoing the cognitive rehabilitation program.
Since group results can mask the variability in individual
responses to cognitive rehabilitation, it is of interest to further
investigate the specific patient factors that are associated with
a more (or less) positive outcome. Undergoing a cognitive
rehabilitation program can be quite time-consuming and
burdensome for patients. Identification of specific patient
characteristics that predict a positive response to cognitive
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rehabilitation could allow us to reassure patients who possess
these characteristics that undergoing this type of intervention
is almost certainly worth the effort. Conversely, if we are
able to identify patients who are less likely to benefit from
the currently available cognitive rehabilitation programs, we
may advise them accordingly. Perhaps more importantly, we
can use the knowledge gained to adapt cognitive rehabilita-
tion programs to yield optimal benefit for a larger percentage
of the target population.
Sociodemographic (e.g., age, sex, and education), clinical
(e.g., radiotherapy), subjective (e.g., self-reported cognitive
symptoms), and/or neuropsychological (pre-intervention
neuropsychological functioning) factors may play a role in
predicting the outcome of cognitive rehabilitation. From a
practical point of view, it would be desirable to be able to
identify patients who are most likely to respond to cognitive
rehabilitation on the basis of information that can be collected
with relatively little effort (e.g., sociodemographics, basic
clinical data). However, use of other patient-reported out-
comes (e.g., cognitive symptoms) and performance indica-
tors (neuropsychological test results) may also provide useful
in maximizing such predictions.
Identifying responsiveness to a cognitive intervention, or
change over time at the individual patient level is compli-
cated by the fact that the reliability of (neuro)psychological
measures can be compromised by such factors as practice
effects and regression to the mean. In recent years, the Reli-
able Change Index (RCI) has been introduced as a possible
means of addressing this problem. The RCI represents a
measure of improvement at the individual level in the context
of observed changes over time in a control group (Evans,
Margison, & Barkham, 1998); it reflects the individual
change beyond that which can be attributed to measurement
error, and practice effects. To date, very few studies have
used RCIs to evaluate cognitive rehabilitation at the indivi-
dual level (e.g., Medalia & Richardson, 2005).
The present study investigated the potential predictors of
individual responsiveness to a cognitive rehabilitation pro-
gram that has previously been demonstrated to be successful
at the group level in patients with gliomas. We examined
whether individual improvement, based on the RCI, is
predicted by sociodemographic and clinical variables, self-
reported cognitive symptoms, and objective neuropsycholo-
gical test performance.
METHOD
Study Sample and Design
For a detailed description of the randomized clinical trial
and of the cognitive rehabilitation program, the reader is
referred to Gehring et al. (2009). Briefly, 366 adult patients
with (primarily low-grade) glioma and favorable prognostic
factors, whose disease was in remission, were screened for
the presence of cognitive symptoms. Those who screened
positive and expressed potential interest in participating in a
cognitive rehabilitation program completed a battery of
neuropsychological tests of attention, memory and executive
functioning. Patients who scored at least one standard
deviation below the mean of a healthy comparison group
(n 5 294; van Boxtel et al., 1998) on at least 4 of 20
neuropsychological variables were considered eligible.
These subjective and objective cognitive eligibility criteria
were used to identify patients who would both be motivated
to participate in the program, and would potentially benefit
from its content.
Eligible patients were randomized to an intervention group
(n 5 70) or to a (waiting list) control group (n 5 70). To
evaluate the effect of the rehabilitation program, the battery
of neuropsychological tests and self-report questionnaires
that was administered at baseline was repeated directly
following cognitive rehabilitation (or an equivalent time
point for the control group), and at 6-months follow-up.
The trial was approved by the institutional review boards
of all participating hospitals and all patients provided written
informed consent.
The Cognitive Rehabilitation Condition and the
Control Condition
The cognitive rehabilitation program (Gehring, Aaronson,
Taphoorn, & Sitskoorn, accepted for publication; Gehring
et al., 2009; for a more detailed description) consisted of
six weekly, individual sessions of 2 hr. The intervention
incorporated both cognitive retraining and strategy training.
For the retraining component of the program, a computer
program (C-Car; Gehring & Sitskoorn, 2004) was developed
which consisted of a series of hierarchically graded tasks,
designed to strengthen various aspects of attention, based on
the patient’s needs. The strategy training consisted of six
integrated psycho-education sessions addressing attention,
memory and executive function. These sessions included both
didactic and practical elements aimed at teaching patients
to compensate for impaired cognitive functions. Patients were
also given weekly ‘‘homework’’ assignments to supplement
both the retraining and strategy elements of the program. The
waiting list control group received usual care (i.e., regular
medical follow-up; no cognitive interventions), and was given
the opportunity to follow the program at completion of
the trial.
Results at the Group Level
For a detailed description of the trial results, the reader is
referred to Gehring et al. (2009). To summarize, at immediate
post-treatment, the intervention group reported significantly
fewer cognitive symptoms and less symptom burden than the
control group. At 6-months follow-up, the intervention group
performed significantly better than the control group on a
total of six neuropsychological test variables of attention and
verbal memory, and reported significantly less mental fati-
gue. Group differences in other subjective outcomes were no
longer statistically significant at 6-months follow-up.
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Study Measures
The neuropsychological and self-report measures of cogni-
tive symptoms that were used in this report are summarized in
Table 1.
Outcome Measures
For the current analyses, the six neuropsychological mea-
sures of attention and verbal memory for which statistically
significant group differences were observed at 6-months
follow-up (Gehring et al., 2009) (see Neuropsychological
measures in Table 1) were selected for further investigation at
the individual level using a standardized regression-based
RCI (McSweeny, Naugle, Chelune, & Luders, 1993). One
global dichotomous measure of improvement was calculated
(see Statistical Methods), based on the RCIs of these six
measures, that distinguished between patients who improved
reliably on at least one of the six measures (‘‘improvers’’) and
those who did not (‘‘non-improvers’’).
Predictors
Potential predictors of outcome (Table 2) that were included
in the analyses were: sociodemographics, clinical variables,
self-reported cognitive symptoms, and neuropsychological
test results. As all patients attended all sessions, ‘‘dose of
therapy’’ was not a relevant predictor variable.
Although we considered calculating a composite baseline
neuropsychological score based on Z-scores, this was not
possible because normative data were not available for all
six neuropsychological measures that were also used for the
global RCI outcome.
Statistical Methods
For each program participant, change in the six neuro-
psychological performance measures was calculated by the
Reliable Change Index (RCI), reflecting change at the indi-
vidual level in the context of observed changes for the control
group. While several variants of the RCI have been proposed
Table 1. Details of neuropsychological and subjective cognitive measures
Neuropsychological measures (tests)
Attention
SCWT Stroop Color-Word Test (Hammes, 1971; Stroop, 1935), subtest:
Card III (time in seconds) 2 Attentional inhibition of a
dominant response
DS Digit Span of the WAIS-R (Luteijn & Van der Ploeg, 1983),
subtests:
Forward (span: 0–8) 1 Immediate verbal recall
Backward (span: 0–7) 1 Working memory
LDST Letter Digit Substitution Test (Jolles, Houx, Van Boxtel, & Ponds,
1995), subtest:
90 Sec Writing (number correct: 0–125) 1 Pychomotor speed and speed of
information processing
Verbal Memory
VVLT Visual Verbal Learning Test, direct and delayed recall (Brand &
Jolles, 1987), subscores:
Trial 1 (number correct: 0–15) 1 Immediate verbal span




CFS Cognitive Functioning Scale of the Medical Outcomes Study
(MOS) Health Survey questionnaire battery (Stewart, Ware,
Sherbourne, & Wells, 1992)
Self-reported frequency of
cognitive symptoms
Total score (6–36) 1
Burden Study-specific measure Self-reported burden of the CFS
symptomsTotal (3–18) 1 of three questions on the impact of the cognitive
complaints on daily life, worry about the cognitive complaints,
being troubled by the cognitive complaints
CFQ Cognitive Failure Questionnaire (CFQ) (Broadbent, Cooper,
FitzGerald, & Parkes, 1982; Ponds, Rozendaal, & Jolles)
Self-reported cognitive failures
in daily life
Total score (0–100) 2
Note. 1 5 Higher score indicates better (performance) score; 2 5 Higher score: worse (performance) score; In parentheses: Score/scale ranges.
258 K. Gehring et al.
(Maassen, Bossema, & Brand, 2009), all reflect the ratio of an
estimate of the true change in the numerator and a corre-
sponding (measurement) error in the denominator (Maassen
et al., 2009). For the current study, a standardized regression-
based approach to the RCI was used (McSweeny et al.,
1993), that uses the available information of the control
Table 2. Candidate predictors of improvement: Descriptives and correlations (Pearson’s correlation and Phi coefficient) with ‘reliable
improvement on at least one of the six neuropsychological measures’ in the intervention group
Predictor variables Descriptives Correlation p
Demographic variables
(personal interview)
Age Mean: 41.8; SD: 9.5 2.385 .002**
Sex (male/female) M: 36 (56%) F: 28 (44%) .088 .488
Education (low-medium/high) L-M: 32 (50%) H: 32 (50%) .318 .010*
Currently employed (no/yes) N: 25 (39%) Y: 39 (61%) .185 .142
Medical variables
(medical record)
Disease duration (median: 4.8; range 0.8238.9:
dichotomized: 0.525 years/.5 years)
,5: 33 (52%) .5: 31 (48%) 2.307 .014*
Years since last tumor treatment (log) Median: 2.6; Range: 0.6221.2 2.210 .106
Hemisphere of lesion (left/right; 2 bilateral lesions
excluded)
L: 33 (52%) R: 29 (45%) .076 .557
Tumor classification (astrocytic/oligodendroglial;
4 without histopathological diagnosis excluded)
A: 30 (47%) O: 30 (47%) .068 .605
Radiotherapy in history (no/yes) N: 25 (39%) Y: 39 (61%) 2.010 .936
Epileptic seizures in last year (no/yes) N: 27 (42%) Y: 37 (58%) .260 .038*
Comorbidityf (no/yes) N: 24 (38%) Y: 40 (62%) 2.312 .012*
Tumor grade (low-grade/anaplastic glioma) –
excluded from analyses due to small cell sizes
L: 54 (84%) A: 10 (16%)
Anti-epileptic drug use (no/yes) – excluded from
analyses due to small cell sizes
N: 10 (16%) Y: 54 (84%)
Chemotherapy (no/yes) – excluded from analyses
due to small cell sizes
N: 57 (89%) Y: 7 (11%)
Subjective variables
(questionnaires)
Total Cognitive Functioning Scale (CFS) Mean: 20.9; SD: 4.2 .070 .588
Burden of the cognitive symptoms Mean 9.8; SD: 2.9 .092 .472







Median: 98.5; Range: 522254 2.102 .422
Digit Span Forward Mean: 5.3; SD: 1.0 2.034 .792
Digit Span Backward Mean: 4.6; SD: 1.1 2.180 .156
Letter Digit Substitution Test 90 Sec Writing Mean: 43.9; SD: 8.4 .263 .036*
Visual Verbal Learning Test Trial 1 Mean: 5.8; SD: 2.3 .119 .351
Visual Verbal Learning Test Delayed Recall Mean: 9.5; SD: 3.0 .022 .866
One (1) cognitively disturbed domain versus
multiple (>1) domains disturbed at baseline
1: 49 (77%) >1: 15 (23%) .082 .519
Note. *p , .05, two-tailed. **p , .01, two-tailed; log 5 logarithmically transformed, rec 5 reciprocally transformed; fother concurrent diseases or disease
symptoms not related to the brain tumor varying from chronic eczema to diabetes or cardiovascular disease.
Table 3. Reliably improved individuals in the intervention group (N 5 64) and in the control group (N 5 63)
Neuropsychological test variable Intervention group Control group
N improved % improved N improved % improved
Stroop Color-Word Test Card III 4 6% 5 8%
Digit Span Forward 13 20% 3 5%
Digit Span Backward 17 27% 5 8%
Letter Digit Substitution Test 90-Sec Writing 8 13% 1 2%
Visual Verbal Learning Test Trial 1 13 20% 4 6%
Visual Verbal Learning Test Delayed Recall 11 17% 4 6%
Reliably improved in at least one of the six measures 38 59% 16 25%
Note. Number and percentage of improvers at six months follow-up per neuropsychological test variable, and number and percentage of patients who
improved reliably in at least one of the six neuropsychological measures (global RCI outcome).
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group more thoroughly than other types of RCIs (Maassen
et al., 2009). Practice effect is estimated by means of a
regression of the post-test on the pre-test score in the control
group; subsequently the relationship between practice effect
and the initial score of an individual is used. The standard
error of prediction of the control group is used as the standard
error in the denominator. The index that is calculated is
compared to the critical value for a one-sided t test with
n 5 64. The reader is referred to the Appendix for further
details of the RCI formula used in this study.
Finally, a global, dichotomous measure of reliable
improvement was created to distinguish between patients
who improved reliably on at least one of the six measures
(‘‘improvers’’) and those who did not (‘‘non-improvers’’).
This global measure was used as the dependent variable in
the analyses.
Because of the large number of possible predictors (21;
see Table 2) and the relatively small sample size (n 5 64),
univariate correlations (Pearson’s correlation and Phi coeffi-
cient) between (both dichotomous and continuous) predictor
variables and the global RCI were first calculated. Indepen-
dent variables that correlated with the global RCI outcome at
the p , .05 level were included in subsequent multivariate
analyses. Dichotomous predictor variables with cell sizes
that were too small were excluded from the analyses. Vari-
ables that were not normally distributed (an assumption
for Pearson’s correlations) were transformed to normalize
distributions, or were dichotomized.
Clusters of one or more variables that correlated sig-
nificantly with the global RCI outcome at the univariate level
were included in the logistic regression analyses according to a
pre-specified hierarchy: sociodemographic variables, clinical
variables, self-reported cognitive symptoms, and baseline
neuropsychological test results. This hierarchical ordering
was chosen to reflect the ease with which these data could be
collected in daily clinical practice. That is, sociodemographic
and clinical data can be relatively easily extracted from the
medical records, while patient self-reported symptoms and
objective neuropsychological test results require additional
and, in the case of the neuropsychological tests, quite sub-
stantial data collection efforts. The final model was composed
of those variables that contributed significantly to predicting
reliable improvement in at least one of the six neuropsycho-
logical measures (the global RCI outcome).
To investigate whether the factors identified as being
multivariate predictors of improvement within the interven-
tion group might also be predictive of improvement in neuro-
psychological functioning in general, an additional logistic
regression analysis was conducted for the entire study sample
(the intervention and the control group combined) in which,
in addition to the identified predictor variables, both the
group variable and group 3 predictor interaction terms were
included in the model.
Assumptions concerning (absence of) outliers/influential
cases, empty cells and multicollinearity were tested for all
of the logistic regression models. Variables that had been
transformed or dichotomized for the univariate analyses
remained modified for the logistic regression analyses. For all
logistic regression analyses, a p value ,.05 was considered
statistically significant. Nagelkerke’s pseudo R2 was used to
provide an indication of the substantive significance of the
logistic regression model (analogous to a R2 value as reported
with multiple regression; Field, 2005).
Because of the relatively small sample size, a bootstrap
sampling estimation was performed in which 2000 versions
of the training group were generated to estimate regression
coefficients and confidence intervals with a minimum of
assumptions.
Finally, supplemental data on the area under the curve,
sensitivity, specificity, positive (PPV) and negative (NPV)
predictive values, and classification accuracy were calculated
for both predictors, education and age, in the intervention
group, using information from a receiver operating character-
istic (ROC) curve. As age is a continuous measure, determi-
nation of these data depends on the cutoff used for age. This
cutoff was determined on the basis of the smallest number of
misclassifications (Youden’s Index; Youden, 1950), that is,
on the optimal combination of sensitivity and specificity, by
summing these two values for each value of age in the sample
(a table provided by the SPSS ROC curve output).
For all statistical tests, the Statistical Package for the
Social Sciences (SPSS; SPSS Inc. Chicago, IL) version 17.0
was used.
RESULTS
Follow-up data were available of 64 intervention group
patients. There were no statistically significant differences in
sociodemographic, clinical, self-reported cognitive symptoms
or baseline neuropsychological test scores between these
64 patients and the 63 control group patients whose baseline
and follow-up neuropsychological test scores were used for
calculating the RCI.
RCI Results per Measure and Global RCI-Score
Fifty-nine percent of the patients in the intervention group,
as compared to 25% in the control group (w2(1) 5 14.997;
p , .001), improved reliably (i.e., corrected for measurement
errors and practice effects) on at least one of the six neuro-
psychological measures (the global RCI outcome; see Table 3,
also for the number and percentage of reliably changed indivi-
duals in both groups per neuropsychological test variable).
Variables Associated Significantly with Reliable
Change in Neuropsychological Functioning
at the Univariate Level
Variables that were not normally distributed were transformed
(logarithmically for ‘‘years since last tumor treatment’’, or
reciprocally for ‘‘Stroop color-word test’’; see Table 2) to
normalize distributions. One variable (‘‘disease duration’’) was
dichotomized to solve problems with normality even after
transformation, with the cutoff based on the median disease
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duration of 5 years. It should be noted that, since the majority
of patients had a low-grade glioma, received anti-epileptic
drugs and had not received chemotherapy, variables regarding
tumor grade, anti-epileptic drugs and chemotherapy were not
included in the analyses as the numbers of patients in these
cells were too small.
The following variables were found to correlate sig-
nificantly with reliable improvement in neuropsychological
functioning over time (see also Table 2): From the socio-
demographic cluster, age (younger age) and education
(higher level); from the clinical cluster, disease duration (less
than 5 years), epileptic seizures in last year (yes), and
comorbidity (no). None of the self-reported cognitive symp-
tom variables were correlated significantly with outcome.
Of the baseline neuropsychological tests, only letter-digit
substitution score (higher) was associated significantly with
reliable improvement.
Logistic Regression Analyses
In the first logistic regression analysis (see Table 4), the
demographic variables age and education were included as
possible predictors. (Younger) age and (higher) education were
associated with reliable improvement (model w2(2) 5 17.190;
p , .001).
Addition of the clinical variables disease duration, epilep-
tic seizures and comorbidity did not result in a significant
improvement of the model (step/block w2(3) 5 6.582;
p 5 .086). Thus the clinical variables did not contribute sig-
nificantly to the model and therefore these variables were not
included. Finally, inclusion of the letter-digit substitution test
to the existing model did not result in an improvement of the
model (step/block w2(1) 5 .012; p 5 .991).
The final model (model w2(2) 5 17.190; p , .001) pre-
dicting reliable change in the participants that had followed
the cognitive rehabilitation program six months earlier was
similar to the initial model and included age (p 5 .003) and
education (p 5 .011) only. A Nagelkerke’s pseudo R2 of .318
indicated moderate explanatory power of the model. The
odds of improvement over time increased 0.9 times per year
of age (range, 23 to 59 years), and were 4.7 times greater for
higher (vs. low to medium) education level. The bootstrap
sampling estimation confirmed these results.
For education, the area under the ROC curve in the
intervention group was .66 (asymptotic 95% confidence
interval: .585–.850). The sensitivity was 63% and the spe-
cificity was 69%. The overall classification accuracy was
65%. The PPV (i.e., given a higher education the chance
to improve) was 75%, and the NPV (i.e., given a lower
education, the chance of no improvement) was 56%. For
age, the area under the ROC curve was .72 (asymptotic
95% confidence interval: .525–.799). At the optimal cutoff
of age 50, sensitivity was 95%, specificity was 50%, and
the overall classification accuracy was 77%. The PPV (i.e.,
given a younger age the chance to improve) was 73% and
the NPV (i.e., given an older age the chance of no
improvement) was 87%.
To investigate whether age and education specifically
predicted intervention-related improvement, or were also
involved in more general improvement, an additional logistic
regression analysis was conducted for the entire study group
(n 5 127) with inclusion of the variables group, age, educa-
tion, and the two-way interaction terms of group 3 age, and
group 3 education. A high correlation was observed between
the group variable and the interaction term group 3 age
(r(125) 5 .95), resulting in a problem with multicollinearity.
For this reason, age was centered around the total group mean
age of 41.8 years for use in the interaction term.
This model (model w2(5) 5 41.545; p , .001; Table 4)
confirmed that the intervention (p 5 .014) was associated
significantly with improvement in the entire group, as was
(higher) education (p 5 .024). (Centered) age, however,
was only significant when incorporated in the interaction
term (p 5 .001), indicating that (younger) age moderated
improvement in neuropsychological test performance for the
intervention group, but not for the control group. The odds
of reliable improvement were 5.3 for the patients in the
intervention group (versus the control group), and 4.5 for
patients with higher education (versus low to medium edu-
cation, irrespective of group). The odds ratio for group 3
centered age was .86, indicating that for every year above the
mean age of 41.8 years, the odds of improvement decreased
by a factor of 0.86.
DISCUSSION
The current study investigated the patient characteristics that
predicted individual neuropsychological improvement in
glioma patients 6 months after undergoing a cognitive reha-
bilitation program (Gehring et al., 2009). According to the
criteria used, with measurement errors and practice effects
taken into account, nearly 60% of the 64 patients in the
intervention group had improved reliably on at least one of
the six neuropsychological measures for which statistically
significant intervention effects had been demonstrated at
the group level. Four categories of candidate predictors of
improvement in neuropsychological test performance were
examined at the univariate level and, subsequently, in the
context of a hierarchical logistical regression model. Of all of
the variables examined, only two sociodemographic vari-
ables, age and education, significantly predicted individual
improvement in the intervention group. Younger patients and
those with a higher education had the highest likelihood of
improvement over time. Additional results suggested that age
was a specific, intervention-related predictor of improvement
in neuropsychological functioning; that is, it did not predict
such improvement among those patients not exposed to
the cognitive rehabilitation program. Education, however,
appeared to be a more general predictor of improvement
in neuropsychological functioning, irrespective of whether
patients were exposed to the program.
It should be noted that in calculating the RCI, data on
practice effects as measured in the control group are taken
into account. However, these data are based on ‘‘mean’’
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Table 4. Logistic regression models
95% CI for Exp(B)
Model w2 df p R2 (Nagelkerke) Variables in the equation B SE Wald df Sig. Exp(B) lower upper
1 Age 2.103 .035 8.673 1 .003 .902 .842 .966
Sociodemographic 17.190 2 .000 .318 Education (dich) 1.552 .611 6.457 1 .011 4.721 1.426 15.628
variables Constant 4.055 1.498 7.329 1 .007 57.692
2 Age 2.085 .038 4.922 1 .027 .919 .853 .990
Sociodemographic 23.773 5 .000 .419 Education (dich) 1.236 .657 3.535 1 .060 3.441 .949 12.481
1 clinical variables Comorbidity (dich) 21.129 .678 2.773 1 .096 .323 .086 1.221
Disease duration (dich) 21.101 .631 3.051 1 .081 .332 .097 1.144
Epileptic seizures (dich) .473 .654 .523 1 .469 1.605 .446 5.778
Constant 4.393 1.818 5.840 1 .016 80.865
3 Age 2.102 .038 7.117 1 .008 .903 .839 .973
Sociodemographic 17.203 3 .001 .318 Education (dich) 1.527 .650 5.513 1 .019 4.603 1.287 16.463
1 neuropsychological Letter digit substitution .004 .040 .012 1 .911 1.005 .928 1.087
variables Constant 3.801 2.722 1.951 1 .163 44.764
4 Age 2.103 .035 8.673 1 .003 .902 .842 .966
Final model 17.190 2 .000 .318 Education (dich) 1.552 .611 6.457 1 .011 4.721 1.426 15.628
Constant 4.055 1.498 7.329 1 .007 57.692
Group 1.673 .681 6.039 1 .014 5.327 1.403 20.228
Entire sample 41.545 5 .000 .375 Age (centered) .052 .030 2.936 1 .087 1.053 .993 1.117
Education (dich) 1.500 .666 5.071 1 .024 4.482 1.215 16.536
Group X education (dich) .052 .904 .003 1 .954 1.053 .179 6.192
Group X age (centered) 2.155 .046 11.220 1 .001 .857 .782 .938
Constant 22.045 .556 13.527 1 .000 .129







practice effects for the control group. This means that some
patients exhibit more than average, and others exhibit less
than average practice effects. The 25% of the control group
patients that improved ‘‘reliably’’ (a percentage that is sig-
nificantly different from that observed in the intervention
group) may be those patients with greater than average
improvement. The results of the total group analyses suggest
that education may (also) have moderated neuropsychologi-
cal improvement in the control group, which is probably
related to practice effects.
Furthermore, although the criterion of reliable improve-
ment on at least one of six neuropsychological measures may
seem minimal, it should be noted that the RCI is a very
stringent index, excluding measurement errors and subjecting
the adapted score to statistical testing (a t test). This resulted
in clearly defined groups that could be used for analyses with
reliable results. The difference in proportion of reliably
improved patients in the intervention (59%) versus control
(25%) group was statistically significant (w2(1) 5 14.997;
p , .001). The results of the logistic regression analyses
based on the current criteria with group sizes of 38 reliably
improved versus 26 not (reliably) improved patients were
supplemented by other statistical measures (in particular, the
PPV and NPV of age of 73% and 87%, respectively), and
yielded different predictor variables for the intervention
group as compared to the control group.
The prediction of ‘‘success’’ of the program by age may
reflect the nature and content of the program itself. The game-
like retraining on a notebook computer may have been
more attractive, and familiar to, younger patients. However,
in studies on outcome of patients suffering from acquired
brain injury (without interventions specifically aimed at
treating cognitive deficits), sociodemographic variables
such as age and education/intelligence, have also been pre-
dictive of functioning, in addition to medical injury severity
variables (Chu et al., 2007; Malec & Basford, 1996;
Robertson & Murre, 1999; Sherer et al., 2006). Both older
age (e.g., Chu et al., 2007; Hukkelhoven et al., 2003;
Robertson & Murre, 1999; Sherer et al., 2006) and lower
education (Brooks, McKinlay, Symington, Beattie, &
Campsie, 1987; Grafman, Salazar, Weingartner, Vance, &
Amin, 1986; Robertson & Murre, 1999; Sherer et al., 2006)
have been associated with poorer neuropsychological out-
come in many of these studies.
The finding that age plays a significant role in predicting
(cognitive) recovery may be related to the concept of
brain reserve. There is both epidemiological and biological
evidence that individual differences in the brain allow
some people to cope better than others with brain damage
(Fratiglioni & Wang, 2007; Stern, 2009). These individual
differences stem from quantitative factors such as brain size,
or number of neurons or synapses. Furthermore, brain anat-
omy can be influenced by life experiences, via neurogenesis
and angiogenesis that promote resistance to apoptosis and
indirectly promote neural plasticity (Stern, 2009). As aging
has been related to losses in gray and white matter in medial-
temporal, parietal and frontal areas (Charlton et al., 2006;
Gordon et al., 2008), it has been suggested that these diffuse
age-related losses results in a larger threshold for recovery to
take place (Robertson & Murre, 1999), decreasing the brain’s
reserve (Green et al., 2008; Stern, 2009).
Moreover, brain reserve factors may not only buffer the
outcome of brain damage, and influence the initial cognitive
status after the injury, they may also play a supporting role in
restitution of function or functional reorganization during
recovery (Green et al., 2008). Some of the few studies on
recovery trajectories conducted in brain-injured populations
have suggested that age (but not education) can indeed
moderate improvement in cognitive functioning in patients
with traumatic brain injury (Green et al., 2008; Zwaagstra,
Schmidt, & Vanier, 1996). However, in other studies, factors
such as age (or premorbid intelligence) only predicted the
level of cognitive outcome, rather than influencing the
recovery trajectory (Chu et al., 2007; Green et al., 2008).
With regard to improvement after cognitive rehabilitation
in particular, age has also been reported to play a moderating
role (e.g., Langbaum, Rebok, Bandeen-Roche, & Carlson,
2009; Rohling, Faust, Beverly, & Demakis, 2009; Verhaeghen,
de Mey, Helsen, van Assel, & Vanwijnsberghe, 1992;
Yesavage, Sheikh, Friedman, & Tanke, 1990). Langbaum
and colleagues (2009) studied the different patterns of
response to memory training in 619 healthy older adults and
concluded that higher education and higher baseline cogni-
tive functioning were predictors of (patterns of) memory
improvement. Age had also a moderating effect, although the
relationship to response pattern was possibly not linear.
However, other studies did not find moderating effects of age
(or education) (Medalia & Richardson, 2005; Neely &
Backman, 1995).
Thus, although it is well-known that age (and also educa-
tion) influence (static) performance on neuropsychological
tests, this study demonstrates that these variables may also
moderate the (dynamic) response to cognitive rehabilitation.
In line with this reasoning above, in the current study,
younger patients may have a larger brain reserve capacity for
dealing with the pathological effects of the brain tumor.
It would have been interesting if we, in addition to a proxy
measure of brain reserve (age) also had used some proxy
measure for cognitive reserve in the analyses. Although we
collected data on the DART (the Dutch version of the
NART), a measure of premorbid intelligence, we decided not
to use these data in the analyses as we observed that they were
confounded by hemisphere of lesion. Unfortunately we had
no other measure for cognitive reserve available.
The order in which the variables were analyzed, according
to our pre-specified clinical hierarchy, in combination
with the relatively small power of the study, may have pre-
cluded some other possibly relevant variables from reaching
statistical significance. The clinical variables that were tested
in the multivariate model yielded statistical trends only. The
finding that baseline neuropsychological functioning was
not predictive of improvement following the program runs
contrary to other evidence in the literature (e.g., Fiszdon,
Cardenas, Bryson, & Bell, 2005; Langbaum et al., 2009;
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Strangman et al., 2008). This may, in part, be due to the fact
that we used only one global measure of cognitive improve-
ment, which was also dichotomized, to investigate the rela-
tionship with each of the six baseline neuropsychological test
variables.
Furthermore, we cannot exclude the possibility that the
positive results of the cognitive rehabilitation are not (only)
attributable to the cognitive treatment itself, but might also be
due, at least in part, to other non-specific factors such as the
attention given to the patients. The RCI does not correct for
these effects. We considered it unethical, impractical, and not
credible to include a ‘‘placebo’’ condition in which patients
would be required to attend a series of 2-hr sessions (com-
parable to the intervention group) in which no substantive
rehabilitation program would be offered. However, non-
specific treatment effects as the sole or even primary expla-
nation for the improvements in objective test performance is
less likely, considering the initially equal improvement in
neuropsychological performance for both groups, and the
intervention effect observed after a 6-month interval, in
which possible placebo effects may be assumed to be absent.
The results of this study suggest that younger patients with
a glioma are more likely to benefit from the cognitive reha-
bilitation program. As younger age at diagnosis is a major
prognostic factor in brain cancer (Schiff, Brown, & Giannini,
2007), it is useful to know that these patients are also most
likely to benefit from the intervention. This should not,
however, suggest that cognitive rehabilitation programs
should not be offered to older patients. Rather, greater effort
should be devoted to adapting our current training program to
increase its effectiveness among older patients. Brooks and
colleagues (Brooks, Friedman, Pearman, Gray, & Yesavage,
1999), in a study of 268 community-dwelling adults over the
age of 55 years, reported that older participants benefited
from increased training time coupled with a comprehensive
pre-training regimen in memory (mnemonic) rehabilitation.
Thus, pre-training, combined with more sessions over time,
may facilitate program success in older patients.
A secondary, but relevant, finding of the study was that
more highly educated patients were more likely to exhibit
improved cognitive functioning over time, regardless of
whether they participated in the program. This suggests that
(clinical) neuropsychologists or (other) researchers should be
aware that patients with a higher level of education are likely
to show improvement over time after multiple neuropsycho-
logical test assessments.
Future cognitive rehabilitation approaches, in patients with
brain tumors or other diseases that cause cognitive impair-
ment should take the age of participants into account, and
investigate whether adapted intervention characteristics (e.g.,
pretraining, and splitting up sessions) may facilitate enhanced
program effectiveness in older participants.
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APPENDIX
The formula of the Reliable Chang Index (Maassen et al.,
2009; McSweeny et al., 1993) is as follows:





Di 5 difference score: post-test score – pre-test score of the
individual in the intervention group
Dc 5 difference score: mean of post scores of the control
group – mean of pre scores of the control group
bc 5 regression coefficient of post-test on pre-test in the
control group
Xi 5 pre-test score of the individual in the intervention
group
Xc 5 mean of pre-test scores of the control group
Sy 5 standard deviation of the post-test scores of the control
group
rXY 5 test–retest reliability of the pre- and post-test scores in
the control group
RCI . 1.67 (one-sided t-test (N 5 64) with p , 0.05) indi-
cates reliably improved
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